Haleon: latest retail news and insights | ESM Magazine

Haleon To Sell Nicotine Replacement Therapy Business Outside US

Haleon will sell its nicotine replacement therapy business outside the US to a unit of India's Dr. Reddy's for £500 million (€592.23 million), t...

GSK Raises £1.25bn From Offloading Haleon Stake At A Discount

GSK has raised £1.25 billion (€1.46 billion). from selling its entire remaining stake in consumer healthcare firm Haleon, the British drugmaker...

Haleon Posts Tepid Q1 Sales As Demand For Some Products Cool Off

Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates as volumes declined.

Sensodyne-Maker Haleon To Shut UK Manufacturing Site, With More Than 400 Jobs Hit

Consumer healthcare company Haleon is planning to shut down its manufacturing site in Britain by 2026, which will impact 435 jobs, a spokesperson told Reut...

Haleon Names Dawn Allen As New Finance Chief

Consumer healthcare firm Haleon has appointed Tate & Lyle executive Dawn Allen as its new chief financial officer, effective 1 November 2024.

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon To 24%

Consumer healthcare firm Haleon has said that U.S. drugmaker Pfizer, its top shareholder, will sell down its stake in the company to about 24%.

Haleon Reports Sluggish First-Quarter Growth

Despite price increases, Haleon's roster of products has largely kept cheaper private-label competition at bay, although the cost-of-living squeeze and com...